13.	Revenues

	The following table presents our revenues disaggregated by revenue source. Sales and usage-based taxes are excluded from revenues:

		March 31, 2019		March 31, 2018

Research and development agreements	$	416	$	239

The following table presents our revenues disaggregated by timing of recognition:

		March 31, 2019		March 31, 2018

(in U.S. $ thousands)

Product and services transferred at point in time	$	372	$	-
Products and services transferred over time		44		239
	$	416	$	239

The following table presents our revenues disaggregated by geography, based on the billing addresses of our customers:

		March 31, 2019		March 31, 2018

Europe	$	385		204
Canada		31		35
	$	416	$	239

Remaining performance obligations

As at March 31, 2019, the aggregate amount of the transaction price allocated to the remaining performance obligation is $1,510 representing research and development agreements, the majority of which is expected to be recognized in the next twelve months. The Company is also eligible to receive up to $4,479 in research and development milestone payments, approximately 60% of which is expected to be recognized in the next three years, with the remaining 40% expected in the two years following; up to $28,751 in commercial sales milestone payments, the majority of which is expected to be recognized in the next five years, but is wholly dependent on the marketing efforts of our development partners. In addition, the Company is entitled to receive royalties on potential sales.